Handok (002390) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.042x

Based on the latest financial reports, Handok (002390) has a cash flow conversion efficiency ratio of 0.042x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩11.37 Billion ≈ $7.70 Million USD) by net assets (₩267.88 Billion ≈ $181.54 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Handok - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Handok's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Handok carry for a breakdown of total debt and financial obligations.

Handok Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Handok ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
DeviceENG.CO.Ltd
KQ:187870
0.046x
Pluristem
TA:PSTI
-0.235x
Guizhou Zhongyida Co Ltd
SHG:900906
0.253x
American Well Corp
NYSE:AMWL
-0.070x
Sree Rayalaseema Hi-Strength Hypo Limited
NSE:SRHHYPOLTD
0.018x
Daios Plastics S.A.
AT:DAIOS
N/A
Big Ridge Gold Corp
V:BRAU
-0.080x
Sokoman Minerals Corp
V:SIC
-0.070x

Annual Cash Flow Conversion Efficiency for Handok (2011–2024)

The table below shows the annual cash flow conversion efficiency of Handok from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see 002390 company net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ₩289.06 Billion
≈ $195.89 Million
₩-2.79 Billion
≈ $-1.89 Million
-0.010x -109.13%
2023-12-31 ₩340.63 Billion
≈ $230.84 Million
₩35.98 Billion
≈ $24.38 Million
0.106x +32.15%
2022-12-31 ₩381.86 Billion
≈ $258.78 Million
₩30.52 Billion
≈ $20.68 Million
0.080x -17.56%
2021-12-31 ₩384.00 Billion
≈ $260.23 Million
₩37.23 Billion
≈ $25.23 Million
0.097x +52.09%
2020-12-31 ₩381.85 Billion
≈ $258.77 Million
₩24.34 Billion
≈ $16.50 Million
0.064x +149.23%
2019-12-31 ₩343.99 Billion
≈ $233.12 Million
₩8.80 Billion
≈ $5.96 Million
0.026x -72.79%
2018-12-31 ₩313.38 Billion
≈ $212.37 Million
₩29.46 Billion
≈ $19.96 Million
0.094x +302.39%
2017-12-31 ₩290.71 Billion
≈ $197.01 Million
₩6.79 Billion
≈ $4.60 Million
0.023x +179.47%
2016-12-31 ₩289.25 Billion
≈ $196.02 Million
₩-8.50 Billion
≈ $-5.76 Million
-0.029x -160.97%
2015-12-31 ₩303.71 Billion
≈ $205.82 Million
₩14.64 Billion
≈ $9.92 Million
0.048x -59.42%
2014-12-31 ₩307.77 Billion
≈ $208.57 Million
₩36.56 Billion
≈ $24.78 Million
0.119x +276.75%
2013-12-31 ₩294.28 Billion
≈ $199.43 Million
₩9.28 Billion
≈ $6.29 Million
0.032x -26.21%
2012-12-31 ₩287.25 Billion
≈ $194.67 Million
₩12.28 Billion
≈ $8.32 Million
0.043x -75.26%
2011-12-31 ₩278.34 Billion
≈ $188.62 Million
₩48.08 Billion
≈ $32.59 Million
0.173x --

About Handok

KO:002390 Korea Drug Manufacturers - Specialty & Generic
Market Cap
$90.77 Million
₩133.94 Billion KRW
Market Cap Rank
#19561 Global
#1100 in Korea
Share Price
₩10310.00
Change (1 day)
-1.81%
52-Week Range
₩10020.00 - ₩12400.00
All Time High
₩38942.94
About

HANDOK Inc. operates as a pharmaceutical company. The company provides prescription and OTC drugs; medical devices, such as blood pressure monitors, cholesterol monitoring systems, insulin pumps, self-monitoring system of blood glucose, and blood glucose monitoring system; in vitro diagnostic medical devices; as well as life science products. It also offers healthcare products comprising food sup… Read more